If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2020

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK), 1 Jan 2020, In : Leukemia.

Research output: Contribution to journalArticleAcademicpeer-review

Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes

Hanekamp, D., Bachas, C., van de Loosdrecht, A., Ossenkoppele, G. & Cloos, J., 2020, In : Pathology. 52, 2, p. 289-291

Research output: Contribution to journalComment/Letter to the editorAcademic

6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes

Hofer, T. P., van de Loosdrecht, A. A., Stahl-Hennig, C., Cassatella, M. A. & Ziegler-Heitbrock, L., 13 Sep 2019, In : Frontiers in Immunology. 10, 2052.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes

Ping, Z., Chen, S., Hermans, S. J. F., Kenswil, K. J. G., Feyen, J., van Dijk, C., Bindels, E. M. J., Mylona, A. M., Adisty, N. M., Hoogenboezem, R. M., Sanders, M. A., Cremers, E. M. P., Lindenbergh-Kortleve, D. J., Samsom, J. N., van de Loosdrecht, A. A. & Raaijmakers, M. H. G. P., 1 Feb 2019, In : Leukemia. 33, 2, p. 536-541 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients

Huls, G., Chitu, D. A., Havelange, V., Jongen-Lavrencic, M., van de Loosdrecht, A. A., Biemond, B. J., Sinnige, H., Hodossy, B., Graux, C., Kooy, R. V. M., de Weerdt, O., Breems, D., Klein, S., Kuball, J. R., Deeren, D., Terpstra, W., Vekemans, M-C., Ossenkoppele, G. J., Vellenga, E., Löwenberg, B. & 1 othersDutch-Belgian Hemato-Oncology Cooperative Group (HOVON), 1 Jan 2019, In : Blood. 133, 13, p. 1457-1464 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access